Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 21,264 | 29,388 | 27,184 | 33,462 | 23,386 |
| Cost of Goods | 7,845 | 8,716 | 6,250 | 6,315 | 6,083 |
| Gross Profit | 13,419 | 20,672 | 20,934 | 27,147 | 17,303 |
| Operating Expenses | 22,096 | 11,660 | 10,915 | 9,736 | 9,380 |
| Operating Income | -7,832 | 9,728 | 10,269 | 17,726 | 8,006 |
| Other Income | 95 | 138 | 261 | 16 | 58 |
| Pre-tax Income | -7,737 | 9,866 | 10,530 | 17,742 | 8,064 |
| Income Tax | -1,051 | 1,799 | 3,643 | 6,373 | 2,571 |
| Net Income Continuous | -6,686 | 8,067 | 6,887 | 11,369 | 5,493 |
| Net Income | $-6,686 | $8,067 | $6,887 | $11,369 | $5,493 |
| EPS Basic Total Ops | -0.46 | 0.55 | 0.47 | 0.78 | 0.38 |
| EPS Basic Continuous Ops | -0.46 | 0.55 | 0.47 | 0.78 | 0.38 |
| EPS Diluted Total Ops | -0.46 | 0.52 | 0.46 | 0.76 | 0.37 |
| EPS Diluted Continuous Ops | -0.46 | 0.54 | 0.46 | 0.76 | 0.37 |
| EBITDA(a) | $-6,359 | $10,794 | $11,471 | $18,734 | $9,020 |